3311
Allied Health: Determining the Bioequivalence of Generic Inhalers
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Symposium
Moderator:
Anne E. Borgmeyer , DNP RN CPNP AE-C

Learning Objectives:
  1. Identify the differences in regulatory requirements for inhalers
  2. Discuss the different methods of determining bioavailability of inhalers
  3. Describe the pharmacokinetic studies of inhalers
10:45 AM
Use of Methacholine Challenge to Determine Bioequivalence of Beta Agonist Inhalers
Leslie Hendeles, PharmD
Handouts
  • AAAAI-2016.pdf (1015.5 kB)
  • 11:05 AM
    Question & Answer
    11:10 AM
    FDA Requirements
    Gunther Hochhaus, PhD
    11:30 AM
    Question & Answer
    11:35 AM
    Pharmacokinetics of Inhaled Drugs
    Gunther Hochhaus, PhD
    11:55 AM
    Question & Answer
    See more of: Session